zaro

What are signs of Down syndrome on ultrasound?

Published in Fetal Ultrasound Markers 3 mins read

Ultrasound examinations can reveal several "soft markers" or structural anomalies that may indicate an increased risk of Down syndrome during pregnancy, particularly in the second trimester. It's crucial to understand that these findings are not definitive diagnoses but rather indicators that warrant further evaluation.

Understanding Ultrasound Markers for Down Syndrome

While an ultrasound cannot definitively diagnose Down syndrome (Trisomy 21), it plays a vital role in identifying specific features that might suggest a higher probability. These features are often referred to as "soft markers" because they can also be present in typically developing fetuses without Down syndrome. The presence of multiple soft markers, or certain combinations, can significantly elevate the estimated risk.

Common Ultrasound Soft Markers in the Second Trimester

During the second trimester, a detailed ultrasound scan specifically looks for a range of indicators. The most commonly assessed soft markers associated with Down syndrome include:

  • Thickened Nuchal Skin Fold: An increased measurement of the skin fold at the back of the baby's neck. This is one of the more significant markers often considered.
  • Echogenic Intracardiac Foci (EIF): Appears as small, bright spots within the heart, most frequently in the left ventricle. While often benign and isolated, they can sometimes be associated with chromosomal abnormalities.
  • Pyelectasis: Characterized by mild dilation or enlargement of the renal pelvis, a part of the kidney that collects urine.
  • Short Femur Length: When the length of the baby's thigh bone (femur) is shorter than expected for their gestational age.
  • Choroid Plexus Cysts (CPC): Small, fluid-filled sacs found in the choroid plexus of the brain, which is involved in producing cerebrospinal fluid. These are often transient and may resolve on their own.
  • Echogenic Bowel: The fetal bowel appears unusually bright or "echogenic" on the ultrasound, similar in brightness to bone.
  • Ventriculomegaly: Refers to the mild enlargement of the fluid-filled spaces (ventricles) within the baby's brain.

Table of Soft Markers and Their Characteristics

To provide a clearer overview, here's a summary of these soft markers:

Soft Marker Description
Thickened Nuchal Skin Fold Increased measurement of the skin at the back of the fetal neck.
Echogenic Intracardiac Foci Bright spots seen within the heart, often in the left ventricle.
Pyelectasis Mild dilation of the renal pelvis (part of the kidney).
Short Femur Length Femur (thigh bone) shorter than expected for gestational age.
Choroid Plexus Cysts Small, fluid-filled cysts in the brain's choroid plexus.
Echogenic Bowel Fetal bowel appearing unusually bright on ultrasound.
Ventriculomegaly Mild enlargement of the brain's ventricles.

What These Findings Mean

It is important to emphasize that the presence of one or more of these soft markers does not automatically mean a baby has Down syndrome. Many of these findings can be isolated variations, transient, or present in healthy fetuses. For instance, an isolated echogenic intracardiac focus is frequently considered a normal variant. However, when multiple markers are identified, or when a soft marker is found in conjunction with an abnormal first-trimester screening result (like elevated nuchal translucency or specific blood test abnormalities), the likelihood of Down syndrome increases.

Next Steps After Identifying Markers

If ultrasound markers are detected, healthcare providers will typically discuss the findings with the expectant parents and offer further options. These may include:

  • Genetic Counseling: To understand the implications of the findings and discuss risk assessment.
  • Non-Invasive Prenatal Testing (NIPT): A blood test that screens for chromosomal abnormalities by analyzing fetal DNA circulating in the mother's blood.
  • Diagnostic Procedures: Such as amniocentesis or chorionic villus sampling (CVS), which involve obtaining a sample of amniotic fluid or placental tissue for chromosomal analysis. These provide a definitive diagnosis.